Research Article
Microtubule-Associated Protein 4 Is a Prognostic Factor and Promotes Tumor Progression in Lung Adenocarcinoma
Table 2
Univariate and multivariate Cox regression analysis for OS in lung adenocarcinoma patients.
| Variates | Categories | Univariate analysis | Multivariate analysis | HR (95%CI) | value | HR (95%CI) | value |
| Gender | Male versus female | 1.361 (0.843–2.199) | 0.207 | | | Age | >60 versus ≤60 years | 1.058 (0.654–1.711) | 0.818 | | | Differentiation | Poor versus well/moderate | 1.025 (0.602–1.746) | 0.927 | | | pT | T3-4 versus T1-2 | 1.393 (0.771–2.516) | 0.272 | | | pN | N1-3 versus N0 | 2.767 (1.697–4.512) | <0.001 | 2.770 (1.642–4.674) | <0.001 | TNM stage | II-III versus I | 2.474 (1.517–4.036) | <0.001 | | | MAP4 expression | High versus low | 1.714 (1.060–2.771) | 0.028 | 1.655 (1.017–2.692) | 0.042 |
|
|
OS: overall survival; HR: hazard ratio; CI: confidence interval; p: pathological staging; TNM: tumor-node-metastasis; MAP4: microtubule-associated protein 4.
|